Bruno Lapauw
Papers
2
Total Citations
20
H-Index
2
About
Bruno Lapauw is a clinician-scientist whose research bridges immunology, clinical chemistry, and urologic oncology. His most impactful work centers on developing novel diagnostic tools for chronic inflammatory diseases. In a highly cited 2018 study, Lapauw demonstrated how endoglycosidase S enables a simplified clinical chemistry procedure to directly assess serum IgG undergalactosylation—a hallmark of conditions like rheumatoid arthritis, Crohn’s disease, lupus, and steatohepatitis. This breakthrough offers a practical, scalable method for monitoring disease activity, moving beyond research-grade assays toward routine clinical application. In urologic oncology, Lapauw contributed a landmark case report on the minimally invasive, robot-assisted laparoscopic management of bladder paraganglioma, a rare neoplasm. His work highlights the feasibility and safety of advanced surgical techniques for challenging tumors. With over 20 citations across his key publications, Lapauw’s research has direct translational impact, offering clinicians new ways to diagnose and manage chronic inflammation and rare urologic cancers. His contributions exemplify how innovative biochemistry and surgical precision can improve patient care.
Research Focus
Key Achievements
Top Papers
- 1
- 2